Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1242 | 2666 | 30.1 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2079 | 4804 | THROMBOTIC THROMBOCYTOPENIC PURPURA//ADAMTS 13//HEMOLYTIC UREMIC SYNDROME |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | THROMBOTIC THROMBOCYTOPENIC PURPURA | Author keyword | 822 | 73% | 23% | 622 |
2 | ADAMTS 13 | Author keyword | 539 | 75% | 14% | 386 |
3 | TTP | Author keyword | 127 | 52% | 6% | 173 |
4 | THROMBOTIC MICROANGIOPATHY | Author keyword | 100 | 37% | 8% | 219 |
5 | UPSHAW SCHULMAN SYNDROME | Author keyword | 86 | 96% | 1% | 26 |
6 | THROMBOTIC THROMBOCYTOPENIC PURPURA TTP | Author keyword | 64 | 74% | 2% | 48 |
7 | VON WILLEBRAND FACTOR CLEAVING PROTEASE | Author keyword | 60 | 83% | 1% | 34 |
8 | HEMOLYTIC UREMIC SYNDROME | Author keyword | 58 | 23% | 8% | 218 |
9 | MICROANGIOPATHIC HEMOLYTIC ANEMIA | Author keyword | 44 | 59% | 2% | 50 |
10 | ADAMTS13 ACTIVITY | Author keyword | 42 | 94% | 1% | 15 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FACTOR CLEAVING PROTEASE | 901 | 68% | 30% | 800 |
2 | MICROANGIOPATHIES | 289 | 82% | 6% | 170 |
3 | THROMBOTIC THROMBOCYTOPENIC PURPURA | 182 | 29% | 20% | 523 |
4 | HEMOLYTIC UREMIC SYNDROME | 153 | 16% | 33% | 892 |
5 | UPSHAW SCHULMAN SYNDROME | 149 | 86% | 3% | 75 |
6 | TTP | 142 | 70% | 4% | 119 |
7 | ADAMTS13 ACTIVITY | 123 | 78% | 3% | 80 |
8 | ADAMTS 13 | 122 | 52% | 6% | 164 |
9 | VONWILLEBRAND FACTOR MULTIMERS | 97 | 55% | 5% | 122 |
10 | PLASMA EXCHANGE | 77 | 17% | 16% | 417 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura | 2008 | 205 | 58 | 95% |
The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura | 2015 | 3 | 25 | 96% |
Mechanisms of disease - Thrombotic microangiopathies | 2002 | 643 | 97 | 54% |
Syndromes of Thrombotic Microangiopathy | 2014 | 27 | 57 | 39% |
How I treat patients with thrombotic thrombocytopenic purpura: 2010 | 2010 | 101 | 46 | 74% |
VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TIP | 2015 | 4 | 121 | 53% |
Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan | 2011 | 34 | 59 | 97% |
How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome | 2014 | 11 | 35 | 69% |
ADAMTS13 and von Willebrand Factor in Thrombotic Thrombocytopenic Purpura | 2015 | 2 | 86 | 85% |
Pathophysiology of thrombotic thrombocytopenic purpura | 2010 | 62 | 143 | 85% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BLOOD TRANSFUS MED | 38 | 45% | 2.4% | 64 |
2 | SERV HEM HE E | 15 | 88% | 0.3% | 7 |
3 | CENT HEMATOL | 9 | 14% | 2.2% | 59 |
4 | REFERENCE MICROANGIOPATHIES THROMBOT | 8 | 100% | 0.2% | 5 |
5 | DISCOVERY TECH ASSESSMENT | 6 | 71% | 0.2% | 5 |
6 | SERV IMMUNOPATHOL | 5 | 55% | 0.2% | 6 |
7 | BIOSTAT EPIDEMIOL PUBL HLTH MED | 3 | 100% | 0.1% | 3 |
8 | HEMATOL ON AB AIDS VIRUS | 3 | 100% | 0.1% | 3 |
9 | MED MED SPECIALLUIGI VILLA FDN | 3 | 100% | 0.1% | 3 |
10 | PATHOL MED TRANSFUS MED | 3 | 100% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000160756 | RADIATION NEPHROPATHY//SCHISTOCYTE//RADIATION NEPHRITIS |
2 | 0.0000091546 | SHIGA TOXIN//HEMOLYTIC UREMIC SYNDROME//SHIGA TOXIN B SUBUNIT |
3 | 0.0000084998 | T ACTIVATION//POLYAGGLUTINATION//ERYTHROCYTE CHARGE |
4 | 0.0000079235 | ATYPICAL HEMOLYTIC UREMIC SYNDROME//FACTOR H//C3 GLOMERULOPATHY |
5 | 0.0000073180 | VON WILLEBRAND DISEASE//VON WILLEBRAND FACTOR//VWD |
6 | 0.0000060796 | THERAPEUTIC APHERESIS//THERAPEUTIC PLASMA EXCHANGE//PLASMA EXCHANGE |
7 | 0.0000047511 | HELLP SYNDROME//ACUTE FATTY LIVER OF PREGNANCY//ACUTE FATTY LIVER |
8 | 0.0000038035 | DRUG DEPENDENT ANTIBODIES//DRUG INDUCED THROMBOCYTOPENIA//DRUG INDUCED IMMUNE HEMOLYTIC ANEMIA |
9 | 0.0000036535 | TICLOPIDINE//TICLOPIDINE HYDROCHLORIDE//PCA 4230 |
10 | 0.0000035168 | VASCULAR TOXICITY//INTERNAL MED PERIOPERAT ASSESSMENT//BOLUS 5 FLUOROURACIL |